Peter Straub
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Peter Straub has a total of 374 co-authors. Here are the top co-authors by number of shared publications:
- Lea Karatheodoris Davis
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA
4 shared publications - Jaakko Kaprio
Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland
3 shared publications - Maria Niarchou
Department of Medicine, Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, USA
3 shared publications - Stephan Ripke
Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Berlin, Germany
3 shared publications - Teemu Palviainen
Institute for Molecular Medicine FIMM, University of Helsinki, Helsinki, Finland
3 shared publications - Aarno Palotie
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
2 shared publications
Latest Publications
- Open Access
- 23 July 2025
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 118 (4) , 946-953
RAB19, SERPINB9P1, and Pancreatitis in Patients Taking Azathioprine in Routine Clinical Practice: Genome and Transcriptome‐Wide Association Studies
Azathioprine is used to treat several inflammatory and autoimmune diseases. However, its use is limited by serious adverse events, including acute pancreatitis. Prior studies have found an association between the HLA region and thiopurine‐induced acute pancreatitis (TIAP); however, in clinical practice, many patients with pancreatitis do not meet this strict criterion. We aimed to identify additional genes associated with azathioprine‐related pancreatitis using genome‐wide and transcriptome‐wide association studies (GWAS and TWAS) by broadening the definition of pancreatitis. We conducted a retrospective study of azathioprine users with inflammatory conditions. We used electronic health records linked to genomic data from BioVU (Vanderbilt's biobank) and replicated the results using NIH's All of Us. The primary outcome was acute pancreatitis, and the secondary outcome was pancreatic injury. Sixteen patients with pancreatitis and 2085 control subjects were included from BioVU; the All of Us cohort included < 20 patients with pancreatitis and 847 control subjects. The GWAS analysis (adjusted for 10 principal components of genetic ancestry, sex, age, and azathioprine indication) in the BioVU cohort found an association between pancreatic injury and rs2948386 in RAB19 (OR = 3.47, P = 1.46E−8), which was replicated in All of Us (OR = 2.70, P = 4.18E−3). We also conducted a TWAS adjusting for the same factors above and found a significant association between genetically predicted pancreatic expression of SERPINB9P1 with pancreatic injury (BioVU: effect size = 0.42, P = 1.48E‐5; All of Us: effect size = 0.48, P‐value = 0.01). In summary, we identified two new genetic associations for azathioprine‐related pancreatic injury: the predicted expression of SERPINB9P1 and a SNP in RAB19.
- 23 July 2025
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 118 (4) , 946-953
Open AccessRAB19, SERPINB9P1, and Pancreatitis in Patients Taking Azathioprine in Routine Clinical Practice: Genome and Transcriptome‐Wide Association Studies
Azathioprine is used to treat several inflammatory and autoimmune diseases. However, its use is limited by serious adverse events, including acute pancreatitis. Prior studies have found an association between the HLA region and thiopurine‐induced acute pancreatitis (TIAP); however, in clinical practice, many patients with pancreatitis do not meet this strict criterion. We aimed to identify additional genes associated with azathioprine‐related pancreatitis using genome‐wide and transcriptome‐wide association studies (GWAS and TWAS) by broadening the definition of pancreatitis. We conducted a retrospective study of azathioprine users with inflammatory conditions. We used electronic health records linked to genomic data from BioVU (Vanderbilt's biobank) and replicated the results using NIH's All of Us. The primary outcome was acute pancreatitis, and the secondary outcome was pancreatic injury. Sixteen patients with pancreatitis and 2085 control subjects were included from BioVU; the All of Us cohort included < 20 patients with pancreatitis and 847 control subjects. The GWAS analysis (adjusted for 10 principal components of genetic ancestry, sex, age, and azathioprine indication) in the BioVU cohort found an association between pancreatic injury and rs2948386 in RAB19 (OR = 3.47, P = 1.46E−8), which was replicated in All of Us (OR = 2.70, P = 4.18E−3). We also conducted a TWAS adjusting for the same factors above and found a significant association between genetically predicted pancreatic expression of SERPINB9P1 with pancreatic injury (BioVU: effect size = 0.42, P = 1.48E‐5; All of Us: effect size = 0.48, P‐value = 0.01). In summary, we identified two new genetic associations for azathioprine‐related pancreatic injury: the predicted expression of SERPINB9P1 and a SNP in RAB19.
- Open Access
- 12 July 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa
Background: Hidradenitis suppurativa (HS) is a common, chronic and debilitating inflammatory disease that most commonly affects intertriginous skin. Despite its high heritability, the genetic underpinnings of HS remain poorly understood. Objectives: To identify genetic signals associated with HS, determine genetic relationships with other diseases and investigate potential molecular genetic mechanisms. Methods: We performed a genome-wide association meta-analysis of six studies, totalling 4540 patients with HS and > 1 million control participants, and identified genetic correlations with other common diseases. We integrated the HS data with expression quantitative trait loci from 10 trait-relevant tissues, epigenomic and transcriptomic data from human scalp, differential expression data from HS lesions vs. adjacent skin and mesenchymal Hi-C chromatin looping data. To identify functional noncoding variants, we performed transcriptional reporter assays for signals near KLF5 and SOX9. Results: We identified 11 significant HS signals across 7 loci: 4 corresponded to previously reported associations, 4 represented novel signals within known loci and 3 were signals in newly implicated loci. We identified significant genetic correlations between HS and other inflammatory conditions, particularly inflammatory bowel disease, rheumatoid arthritis, type 2 diabetes mellitus and asthma. We prioritized candidate genes for the 11 signals. The risk allele at KLF5 exhibited 10-fold greater transcriptional activity than the nonrisk allele, while risk alleles at SOX9 showed significantly reduced transcriptional activity. Conclusions: Our results provide insights into potential genetic mechanisms underlying HS and suggest potential therapeutic targets for this challenging condition.
- 12 July 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Open AccessGenomic loci and molecular genetic mechanisms for hidradenitis suppurativa
Background: Hidradenitis suppurativa (HS) is a common, chronic and debilitating inflammatory disease that most commonly affects intertriginous skin. Despite its high heritability, the genetic underpinnings of HS remain poorly understood. Objectives: To identify genetic signals associated with HS, determine genetic relationships with other diseases and investigate potential molecular genetic mechanisms. Methods: We performed a genome-wide association meta-analysis of six studies, totalling 4540 patients with HS and > 1 million control participants, and identified genetic correlations with other common diseases. We integrated the HS data with expression quantitative trait loci from 10 trait-relevant tissues, epigenomic and transcriptomic data from human scalp, differential expression data from HS lesions vs. adjacent skin and mesenchymal Hi-C chromatin looping data. To identify functional noncoding variants, we performed transcriptional reporter assays for signals near KLF5 and SOX9. Results: We identified 11 significant HS signals across 7 loci: 4 corresponded to previously reported associations, 4 represented novel signals within known loci and 3 were signals in newly implicated loci. We identified significant genetic correlations between HS and other inflammatory conditions, particularly inflammatory bowel disease, rheumatoid arthritis, type 2 diabetes mellitus and asthma. We prioritized candidate genes for the 11 signals. The risk allele at KLF5 exhibited 10-fold greater transcriptional activity than the nonrisk allele, while risk alleles at SOX9 showed significantly reduced transcriptional activity. Conclusions: Our results provide insights into potential genetic mechanisms underlying HS and suggest potential therapeutic targets for this challenging condition.
- Open Access
Genome-wide association studies of binge-eating behaviour and anorexia nervosa yield insights into the unique and shared biology of eating disorder phenotypes
Eating disorders—including anorexia nervosa (AN), bulimia nervosa, and binge eating disorder—are clinically distinct but exhibit symptom overlap and diagnostic crossover. Genomic analyses have mostly examined AN. We conducted the first genomic meta-analysis of binge-eating behaviour (BE; 39,279 cases, 1,227,436 controls), alongside new analyses of AN (24,223 cases, 1,243,971 controls) and its subtypes (all European ancestries). We identified six loci associated with BE, including loci associated with higher body mass index (BMI) and impulse-control behaviours. AN GWAS yielded eight loci, validating six loci. Subsequent polygenic risk score analysis demonstrated an association with AN in two East Asian ancestry cohorts. BE and AN exhibited similar positive genetic correlations with psychiatric disorders, but opposing genetic correlations with anthropometric traits. Most of the genetic signal in BE and AN was not shared with BMI. We have extended eating disorder genomics beyond AN; future work will incorporate multiple diagnoses and global ancestries.
Open AccessGenome-wide association studies of binge-eating behaviour and anorexia nervosa yield insights into the unique and shared biology of eating disorder phenotypes
Eating disorders—including anorexia nervosa (AN), bulimia nervosa, and binge eating disorder—are clinically distinct but exhibit symptom overlap and diagnostic crossover. Genomic analyses have mostly examined AN. We conducted the first genomic meta-analysis of binge-eating behaviour (BE; 39,279 cases, 1,227,436 controls), alongside new analyses of AN (24,223 cases, 1,243,971 controls) and its subtypes (all European ancestries). We identified six loci associated with BE, including loci associated with higher body mass index (BMI) and impulse-control behaviours. AN GWAS yielded eight loci, validating six loci. Subsequent polygenic risk score analysis demonstrated an association with AN in two East Asian ancestry cohorts. BE and AN exhibited similar positive genetic correlations with psychiatric disorders, but opposing genetic correlations with anthropometric traits. Most of the genetic signal in BE and AN was not shared with BMI. We have extended eating disorder genomics beyond AN; future work will incorporate multiple diagnoses and global ancestries.
- Open Access
Genome-wide association study of borderline personality disorder identifies 11 loci and highlights shared risk with mental and somatic disorders
We conducted the largest genome-wide meta-analysis of borderline personality disorder (BPD) to date, with a discovery sample of 12,339 cases and 1,041,717 controls, and a replication study of 685 cases and 107,750 controls (all participants of European ancestry). We identified 11 independent associated genomic loci, and nine risk genes in the gene-based analysis. We observed a single-nucleotide polymorphism (SNP) heritability of 17.3% and derived polygenic scores (PGS) predicted 4.6% of the phenotypic variance in BPD on the liability scale. BPD showed the strongest positive genetic correlations with GWAS of posttraumatic stress disorder, depression, attention deficit hyperactivity disorder, antisocial behavior, and measures of suicide and self-harm. Phenome-wide association analyses using BPD-PGS confirmed these associations and additionally revealed associations with general medical conditions including obstructive pulmonary disease and diabetes. The present analyses highlight BPD as a polygenic disorder, with the genetic risk showing substantial overlap with psychiatric and physical health conditions.
Open AccessGenome-wide association study of borderline personality disorder identifies 11 loci and highlights shared risk with mental and somatic disorders
We conducted the largest genome-wide meta-analysis of borderline personality disorder (BPD) to date, with a discovery sample of 12,339 cases and 1,041,717 controls, and a replication study of 685 cases and 107,750 controls (all participants of European ancestry). We identified 11 independent associated genomic loci, and nine risk genes in the gene-based analysis. We observed a single-nucleotide polymorphism (SNP) heritability of 17.3% and derived polygenic scores (PGS) predicted 4.6% of the phenotypic variance in BPD on the liability scale. BPD showed the strongest positive genetic correlations with GWAS of posttraumatic stress disorder, depression, attention deficit hyperactivity disorder, antisocial behavior, and measures of suicide and self-harm. Phenome-wide association analyses using BPD-PGS confirmed these associations and additionally revealed associations with general medical conditions including obstructive pulmonary disease and diabetes. The present analyses highlight BPD as a polygenic disorder, with the genetic risk showing substantial overlap with psychiatric and physical health conditions.
- Open Access
- 13 November 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-13
Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction
Myasthenia gravis (MG) is a rare autoantibody-mediated disease affecting the neuromuscular junction. We performed a genome-wide association study of 5708 MG cases and 432,028 controls of European ancestry and a replication study in 3989 cases and 226,643 controls provided by 23andMe Inc. We identified 12 independent genome-wide significant hits (P < 5e−8) across 11 loci. Subgroup analyses revealed two of these were associated with early-onset (at age P = 5.12e−9). With this work, we aim to enhance our understanding of the genetic architecture of MG.
- 13 November 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-13
Open AccessGenome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction
Myasthenia gravis (MG) is a rare autoantibody-mediated disease affecting the neuromuscular junction. We performed a genome-wide association study of 5708 MG cases and 432,028 controls of European ancestry and a replication study in 3989 cases and 226,643 controls provided by 23andMe Inc. We identified 12 independent genome-wide significant hits (P < 5e−8) across 11 loci. Subgroup analyses revealed two of these were associated with early-onset (at age P = 5.12e−9). With this work, we aim to enhance our understanding of the genetic architecture of MG.
- Open Access
- 1 January 2022
- Published by Bölcsészettudományi Kutatóközpont
- Vol. 4.1., 11-13
Gondolatok a 80 éves Tomka Péterről és a Hadak útján konferenciasorozatról
- 1 January 2022
- Published by Bölcsészettudományi Kutatóközpont
- Vol. 4.1., 11-13
Open AccessGondolatok a 80 éves Tomka Péterről és a Hadak útján konferenciasorozatról
- 27 September 2021
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 51, e95-e96
TU3. A PHENOME-WIDE ASSOCIATION STUDY OF POLYGENIC RISK FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER ACROSS TWO GENETIC ANCESTRIES IN ELECTRONIC HEALTH RECORD DATA
- 27 September 2021
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 51, e95-e96
TU3. A PHENOME-WIDE ASSOCIATION STUDY OF POLYGENIC RISK FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER ACROSS TWO GENETIC ANCESTRIES IN ELECTRONIC HEALTH RECORD DATA